Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.
The Precision Medicine Software market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Precision Medicine Software market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Precision Medicine Software Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Precision Medicine Software market are:
Qiagen
NantHealth, Inc
Translational Software, Inc
Human Longevity, Inc
Foundation Medicine, Inc
IBM Watson Group
Tempus Labs, Inc
2bPrecise LLC
Fabric Genomics
Allscripts
AstraZeneca plc
Abbott Laboratories
Merck & Co., Inc
Pfizer, Inc
GlaxoSmithKline plc
Koninklijke Philips N.V
N-of-One, Inc
Sanofi S.A
Roper Technologies
Flatiron Health, Inc
PierianDx, Inc
SOPHiA GENETICS SA
LifeOmic Health, LLC
Syapse, Inc
Sunquest Information Systems Inc
Gene42, Inc

Most important types of Precision Medicine Software products covered in this report are:
Cloud-based
On-premise

Most widely used downstream fields of Precision Medicine Software market covered in this report are:
Healthcare Providers
Research Centers & Government Institutes
Pharmaceutical & Biotechnology Companies
Others

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026